Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-(propan-2-yl)-6-[2-[4-(propan-2-yl)phenoxy]ethoxy]-1,3-dihydro-2H-benzimidazol-2-one
-
-
1-ethyl-6-[2-(3-fluorophenoxy)ethoxy]-1,3-dihydro-2H-benzimidazol-2-one
-
-
1-ethyl-6-[2-[4-(propan-2-yl)phenoxy]ethoxy]-1,3-dihydro-2H-benzimidazol-2-one
-
-
1-ethyl-6-[[4-(trifluoromethyl)phenyl]methoxy]-1,3-dihydro-2H-benzimidazol-2-one
-
-
1-methyl-6-(3-phenylpropoxy)-1,3-dihydro-2H-benzimidazol-2-one
-
-
2,3-Butanedione
-
10 mM, complete inhibition after 50 min in borate buffer, inhibition is fully reversible upon removal of borate
2,4-pentandione
-
0.3 mM, approx. 90% inhibition of holoenzyme
4-chloromercuribenzoate
-
0.1 mM, 90-95% inhibition
4-deoxypyridoxine 5'-phosphate
4-Pyridoxic acid phosphate
-
0.1 mM, 33.5% inhibition
5-[(3,4-dichlorophenyl)methoxy]-1,3-dihydro-2H-indol-2-one
-
-
5-[(3,4-dichlorophenyl)methoxy]-1H-indole-2,3-dione
-
-
5-[(3,4-dichlorophenyl)methoxy]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one
-
-
5-[(3-chlorophenyl)methoxy]-1H-indole-2,3-dione
-
-
5-[(3-chlorophenyl)methoxy]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one
-
-
5-[(3-fluorophenyl)methoxy]-3-(propan-2-yl)-1,3-dihydro-2H-indol-2-one
-
-
5-[(4-fluorophenyl)methoxy]-1,3-dihydro-2H-indol-2-one
-
-
5-[(4-fluorophenyl)methoxy]-1H-indole-2,3-dione
-
-
5-[2-(4-fluorophenyl)ethoxy]-1,3-dihydro-2H-indol-2-one
-
-
5-[2-(4-fluorophenyl)ethoxy]-1H-indole-2,3-dione
-
-
6-[(3,4-dichlorophenyl)methoxy]-1-methyl-1,3-dihydro-2H-benzimidazol-2-one
-
-
6-[(3-chlorophenyl)methoxy]-1-methyl-1,3-dihydro-2H-benzimidazol-2-one
-
-
6-[(4-chlorophenyl)methoxy]-1-methyl-1,3-dihydro-2H-benzimidazol-2-one
-
-
ammonium sulfate
-
1.9 M, E II: activation at short incubation time, E I: complete inactivation after 10 h incubation; inactivation of isozyme E-I after 10 h
citrate-phosphate buffer
-
-
diethyldicarbonate
-
1.2 mM, complete inactivation after 10 min, activity decrease of 60% can be restored by a 20 min incubation with 900 mM hydroxylamine, pyridoxal 5'-phosphate oxime protects from inactivation, inactivation is due to modification of histidine residues
Fe2+
-
2.85 mM, 44% inhibition of pyridoxamine 5'-phosphate oxidation, 81% inhibition of pyridoxine oxidation
Fe3+
-
2.85 mM, 26% inhibition of pyridoxamine 5'-phosphate oxidation, 50% inhibition of pyridoxine oxidation
guanidine hydrochloride urea
-
both activates and denatures the enzyme
Phenylglyoxal
-
pyridoxal 5'-phosphate protects
pyridoxal 5'-phosphate oxime
-
-
pyridoxaloxime 5'-phosphate
pyridoxamine 5'-phosphate
-
substrate inhibition above 0.0006 mM
Urea
-
both activates and denatures the enzyme, reversible inactivation above 2.5 M, half-time of inactivation is 46 min at 2 M and 37°C
4-deoxypyridoxine 5'-phosphate
-
competitive inhibition
4-deoxypyridoxine 5'-phosphate
-
0.1 mM, 42% inhibition
4-deoxypyridoxine 5'-phosphate
-
-
Cd2+
-
2.85 mM, 82% inhibition of pyridoxamine 5'-phosphate oxidation, 27% inhibition of pyridoxine oxidation
Cd2+
-
0.5 mM, isozyme E I: insensitive, isozyme E II: 44% inhibition; 44% reduced activity of isozyme E-II, no inhibition of isozyme E-I
Cu2+
-
1 mM, 90-95% inhibition
Cu2+
-
2.85 mM, 38% inhibition of pyridoxamine 5'-phosphate oxidation, 23% inhibition of pyridoxine oxidation
Hg2+
-
1 mM, 90-95% inhibition
Hg2+
-
2.85 mM, 30% inhibition of pyridoxamine 5'-phosphate oxidation, 2% inhibition of pyridoxine oxidation
Hg2+
-
0.5 mM, isozyme E I: insensitive, isozyme E II: 54% inhibition; 72% reduced activity of isozyme E-II, no inhibition of isozyme E-I
pyridoxal 5'-phosphate
-
competitive inhibition
pyridoxal 5'-phosphate
-
-
pyridoxal 5'-phosphate
-
competitive inhibitor
pyridoxal 5'-phosphate
-
product inhibition is of a mixed-type nature and results from binding of this vitamer at an allosteric site
pyridoxal 5'-phosphate
the enzyme undergoes an allosteric feedback inhibition by pyridoxal 5'-phosphate (PLP) caused by a strong allosteric coupling between PLP binding at the allosteric site and substrate binding at the active site. One PLP molecule is bound at the allosteric site of one monomer
pyridoxal 5'-phosphate
-
-
pyridoxal 5'-phosphate
-
competitive inhibitor
pyridoxal 5'-phosphate
-
-
pyridoxal 5'-phosphate
-
potent product inhibition
pyridoxal 5'-phosphate
-
competitive inhibition; competitive product inhibition, overview
pyridoxal 5'-phosphate
-
-
pyridoxal 5'-phosphate
-
competitive inhibition
pyridoxal 5'-phosphate
-
-
pyridoxaloxime 5'-phosphate
-
0.2 mM, 80% inhibition
pyridoxaloxime 5'-phosphate
-
-
pyridoxaloxime 5'-phosphate
-
competitive inhibition
pyridoxine 5'-phosphate
-
substrate inhibition
pyridoxine 5'-phosphate
-
substrate inhibition
Zn2+
-
2.85 mM, 92% inhibition of pyridoxamine 5'-phosphate oxidation, 60% inhibition of pyridoxine oxidation
Zn2+
-
0.5 mM, isozyme E I: insensitive, isozyme E II: 54% inhibition; 72% reduced activity of isozyme E-II, no inhibition of isozyme E-I
additional information
-
pyridoxamine 5'-phosphate shows no substrate inhibition
-
additional information
-
no substrate inhibition with pyridoxamine 5'-phosphate
-
additional information
-
no inhibition by tryptophan metabolites
-